Top Czech weightlifter faces two-year doping ban

Image
IANS Prague
Last Updated : Oct 18 2013 | 4:21 PM IST

Czech weightlifter Jiri Orsag faces a two-year suspension for a positive doping test, said Czech weightlifting association head Petr Krol Friday.

Orsag, 24, tested positive for banned substance tamoxifen on two occasions while he was at a training camp in August and September. Tamoxifen, a drug that interrupts the hormone estrogen, is commonly used by athletes as part of a post-cycle treatment to combat the side effects of steroids, reports Xinhua.

Orsag said that he does not know how the drug got in his body.

Krol said he hopes the International Weightlifting Federation (IWF) will decide on Orsag's case during the world championships that will start in Wroclaw, Poland Oct 20.

"An athlete is responsible for his body... The rules are clearly set, he will not avoid punishment," he said. Krol also said he expected an investigation of the case to be launched. "I believe it is not a failure of the system but a mistake of an individual."

The ban will leave Orsag out of the World Championships.

Orsag said he would not comment on his case until an official verdict is issued. He said he would like to continue his weightlifting career after the possible punishment expires.

Orsag is the best weightlifter in Czech Republic, winning five medals at European championships since 2011.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 18 2013 | 4:16 PM IST

Next Story